含有瓦洛的蛋白质:对心血管疾病的潜在治疗点
Nameerah Rakhe1, Lokesh Kumar Bhatt1
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.
Ageing research reviews
|September 23, 2024
概括
含有瓦洛的蛋白质 (VCP) 对细胞过程至关重要,新兴的研究将其与心血管健康联系起来. 了解风险投资方针的理解
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 心血管研究研究心血管研究
背景情况:
- 含有瓦洛辛的蛋白质 (VCP/p97) 对于蛋白质平衡至关重要,并与神经退行性疾病有关.
- 新出现的证据强调了VCP在线粒体功能和细胞应激反应中的关键作用.
- VCP对心血管健康的参与是一个未被充分探索但重要的研究领域.
研究的目的:
- 审查VCP在各种心血管疾病中的多方面的作用.
- 阐明VCP调节线粒体活动和与心脏相关的细胞信号通路的机制.
- 突出VCP作为心血管疾病治疗点的潜力.
主要方法:
- 对VCP和心血管功能现有研究的文献综述.
- 分析VCP在细胞过程中的参与,如蛋白质降解和线粒体调节.
- 检查VCP对mTOR和S-化等信号通路的影响.
主要成果:
- VCP影响线粒体活动,S-化和mTOR信号传递.
- 在心血管压力模型中,VCP显示了潜在的心脏保护作用.
- 静脉动脉功能失调与心肌缺血/再输损伤,心脏缩和心力衰竭有关.
结论:
- VCP在心血管病理生理学和恒温中发挥着重要作用.
- 准VCP可能为治疗心脏病提供新的治疗策略.
- 对VCP的心脏保护机制进行进一步的研究是必要的.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
462
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
462
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
600
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
600
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
584
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
584
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K


